The AESKULISA® Varicella-Zoster Virus IgA, IgG and IgM tests are qualitative and quantitative immunoassays for the detection of human IgA, IgG and IgM antibodies in serum or plasma against Varicella-Zoster Virus. The AESKULISA® Varicella-Zoster Virus IgM supports the detection of acute infections. The AESKULISA® Varicella-Zoster Virus IgG allows the confirmation of pathogen contact and supports the determination of the immune status. The AESKULISA® Varicella-Zoster Virus IgA is used in particular to detect reactivations. The AESKULISA® Varicella-Zoster Virus IgA and AESKULISA® Varicella-Zoster Virus IgG are also used to detect intrathecally produced antibodies in cerebrospinal fluid. The interpretation of the results can only be made in connection with the clinical picture. A diagnosis should not be based solely on the results of the test performed, but should always be made taking into account all clinical and laboratory findings. Further tests should be carried out for confirmation. AESKULISA® immunoassays are suitable for use by healthcare professionals with appropriate professional training in the use of in vitro diagnostics.
6052
Varicella-Zoster Virus IgG
The AESKULISA® Varicella-Zoster Virus IgA, IgG and IgM tests are qualitative and quantitative immunoassays for the detection of human IgA, IgG and IgM antibodies in serum or plasma against Varicella-Zoster Virus. The AESKULISA® Varicella-Zoster Virus IgM supports the detection of acute infections. The AESKULISA® Varicella-Zoster Virus IgG allows the confirmation of pathogen contact and supports the determination of the immune status. The AESKULISA® Varicella-Zoster Virus IgA is used in particular to detect reactivations. The AESKULISA® Varicella-Zoster Virus IgA and AESKULISA® Varicella-Zoster Virus IgG are also used to detect intrathecally produced antibodies in cerebrospinal fluid. The interpretation of the results can only be made in connection with the clinical picture. A diagnosis should not be based solely on the results of the test performed, but should always be made taking into account all clinical and laboratory findings. Further tests should be carried out for confirmation. AESKULISA® immunoassays are suitable for use by healthcare professionals with appropriate professional training in the use of in vitro diagnostics.













